Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | L2HGDH |
| Upstream (Parents) |
|---|
| (<<) TREM2 → L2HGDH |
| (<<) THY1 → L2HGDH |
| (<<) OLR1 → L2HGDH |
| (<<) FAM129A → L2HGDH |
| Downstream (Children) |
|---|
| L2HGDH → UBBP2 (>>) |
| L2HGDH → GART (>>) |
| L2HGDH → L1TD1 (>>) |
| L2HGDH → SPRR2B (>>) |
| L2HGDH → TEX13A (>>) |
| L2HGDH → APBB2 (>>) |
| L2HGDH → RAC3 (>>) |
| L2HGDH → VDAC1P8///LOC100288558///ADAT2///PEX3///FUCA2 (>>) |
| L2HGDH → LOC100289109 (>>) |
| L2HGDH → RFPL1S///RFPL3S (>>) |
| L2HGDH → GALNT8 (>>) |
| L2HGDH → ACACA (>>) |
